Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 1/2
×
Completed
×
belantamab mafodotin
×
Clear all
Filters
3
NCT03544281
2025-03-18
DREAMM 6
GlaxoSmithKline
Phase 1/2
Completed
153 enrolled
91 charts
NCT03732703
2025-02-14
MyDRUG
Multiple Myeloma Research Consortium
Phase 1/2
Completed
103 enrolled
NCT03848845
2024-04-09
DREAMM 4
GlaxoSmithKline
Phase 1/2
Completed
41 enrolled
57 charts